Samples were categorized into low, medium or high AKR1B10 expression based on immunoreactivity, and AKR1B10 expression was significantly lower in adjacent non‐tumour tissues than in HCC tissues (Figure 7O). This evidence concerns the gene AKR1B10 and hepatocellular carcinoma.